COMMUNIQUÉS West-GlobeNewswire

Roche purchases shares in tender offer for 89bio, Inc
30/10/2025
Basel, 30 October 2025 - Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that Roche’s wholly owned subsidiary Bluefin Merger Subsidiary, Inc., has accepted for payment all shares validly tendered and not validly [...]
7 Stars, A New Glory of Yangtze in Global Quality Management
30/10/2025
TAIZHOU, China, Oct. 30, 2025 (GLOBE NEWSWIRE) -- On the evening of October 16 th (European Standard Time), at the EFQM Sustainable Performance Conference and Global Award Gala 2025 held in Spain, Yangtze River [...]
Boehringer Ingelheim acquires license from Kyowa Kirin aimed at developing a novel treatment for patients with autoimmune diseases
30/10/2025
The licensed small molecule program aims to address significant unmet needs for autoimmune diseases . Program adds to Boehringer’s pipeline and its commitment to deliver breakthrough therapies for patients with [...]
Inteleos Opens Africa Office to Advance Basic Obstetric Point of Care Ultrasound (OPOCUS) Certification Across East Africa
30/10/2025
Local Initiative Improves Access to Quality Maternal and Fetal Healthcare ROCKVILLE, Md. and NAIROBI, Kenya, Oct. 30, 2025 (GLOBE NEWSWIRE) -- Inteleos, a global nonprofit healthcare certification organization, expands [...]
DBV Technologies participe au congrès scientifique annuel de l'ACAAI
30/10/2025
Châtillon, France, le 30 octobre 2025 DBV Technologies participe au congrès scientifique annuel de l'ACAAI DBV Technologies (Euronext : DBV – ISIN : FR0010417345 – Nasdaq Stock Market : DBVT – CUSIP : 23306J309) une [...]
DBV Technologies to Participate in Upcoming ACAAI 2025 Annual Scientific Meeting
30/10/2025
Châtillon, France, October 30, 2025 DBV Technologies to Participate in Upcoming ACAAI 2025 Annual Scientific Meeting DBV Technologies (Euronext: DBV – ISIN: FR0010417345 – Nasdaq Stock Market: DBVT – CUSIP: 23306J309), [...]
Pharming Group to participate in Fireside Chat at Jefferies Global Healthcare Conference in London
30/10/2025
Leiden, the Netherlands, October 30, 2025: Pharming Group N.V. (“Pharming”) (Euronext Amsterdam: PHARM/Nasdaq: PHAR) announces that Pharming management will participate in the Jefferies Global Healthcare Conference in [...]
Correcting and Replacing Wave Life Sciences Announced Positive Target Engagement Data from INLIGHT Clinical Trial of WVE-007 for Obesity During Annual Research Day
30/10/2025
This press release corrects and replaces the company’s press release issued today, 10/29, at 4:15 p.m. ET in order to correct a typographical error in the first sub-bullet under “WVE-007 (GalNAc-siRNA)” – “Next steps.” [...]
Latest Data of InnoCare's Zurletrectinib Orally Presented at SIOP 2025
30/10/2025
BEIJING, Oct. 29, 2025 (GLOBE NEWSWIRE) -- InnoCare Pharma (HKEX: 09969; SSE: 688428), a leading biopharmaceutical company focusing on the treatment of cancer and autoimmune diseases, announced today that the latest [...]
Ascentage Pharma to Participate in Two Upcoming Investor Conferences in November 2025
30/10/2025
ROCKVILLE, Md. and SUZHOU, China, Oct. 29, 2025 (GLOBE NEWSWIRE) -- Ascentage Pharma Group International (NASDAQ: AAPG; HKEX: 6855) (“ Ascentage Pharma ” or the “ Company ”), a global, commercial stage, integrated [...]
Specialist Direct's ‘Mira’ Partners with dacadoo to Transform Recovery Management and Wellness Outcomes
30/10/2025
Strategic integration of advanced health engagement technology to enhance recovery journeys and promote healthier lifestyles Zurich, Switzerland, Oct. 29, 2025 (GLOBE NEWSWIRE) -- Specialist Direct, a digital health [...]
Patients demand Ford government reimburse wrongful charges at Ford’s private clinics: more than 160 people join Day of Action at Ontario Legislature
29/10/2025
TORONTO, Oct. 29, 2025 (GLOBE NEWSWIRE) -- Patients who have been wrongfully charged for surgeries and diagnostic tests at private clinics were joined by more than 160 supporters at the Ontario Legislature today for a “ [...]
Dianthus Therapeutics Highlights New Claseprubart Data Presented During 2025 AANEM Annual Meeting
29/10/2025
Positive data from Phase 2 MaGic trial presented for claseprubart in generalized Myasthenia Gravis, including new open-label extension data further supporting potential for 300mg/2mL Q4W dosing Phase 3 gMG trial planned [...]
Veru Announces Proposed Public Offering
29/10/2025
MIAMI, FL, Oct. 29, 2025 (GLOBE NEWSWIRE) -- Veru Inc. (NASDAQ: VERU), a late clinical stage biopharmaceutical company focused on developing innovative medicines for the treatment of cardiometabolic and inflammatory [...]
Tectonic Therapeutic Announces Positive Topline Data from Phase 1b Part B Clinical Trial for TX45 in Patients with Group 2 Pulmonary Hypertension in HFrEF
29/10/2025
TX45 improved both left heart function and pulmonary hemodynamics in patients with Group 2 Pulmonary Hypertension in Heart Failure with reduced Ejection Fraction (“PH‑HFrEF”) TX45 was well tolerated in patients with PH‑ [...]
BridgeBio Reports Third Quarter 2025 Financial Results and Business Updates
29/10/2025
- $120.7 million in total third quarter revenue, comprised of $108.1 million of U.S. Attruby® net product revenue, $4.3 million from royalty revenue, and $8.3 million in license and services revenue - As of October 25, [...]
MIMEDX Announces Record Revenue for Third Quarter 2025
29/10/2025
Second Consecutive Quarter of Highest Quarterly Net Sales in MIMEDX History Third Quarter Net Sales of $114 million Grew 35% Year-Over-Year Third Quarter GAAP Net Income and Diluted Earnings Per Share were $17 Million [...]
Spyre Therapeutics to Participate in Upcoming November Investor Conferences
29/10/2025
WALTHAM, Mass., Oct. 29, 2025 (GLOBE NEWSWIRE) -- Spyre Therapeutics, Inc. (NASDAQ: SYRE), a clinical-stage biotechnology company pioneering long-acting antibodies and antibody combinations to redefine the standard of [...]
Teladoc Health Reports Third Quarter 2025 Results
29/10/2025
NEW YORK, NY, Oct. 29, 2025 (GLOBE NEWSWIRE) -- Teladoc Health, Inc. (NYSE: TDOC), the global leader in virtual care, today reported financial results for the three months ended September 30, 2025 (“Third Quarter 2025 [...]

Pages